• Entecavir (BMS200475): Resistance Landscape and Clinical Imp

  2026-04-19

  Explore the evolving landscape of Entecavir resistance in chronic hepatitis B therapy. This in-depth review uniquely analyzes meta-analytic evidence, assay parameters, and clinical implications for advanced HBV research and treatment.

• SM-164: Bivalent Smac Mimetic for Advanced Apoptosis Assays

  2026-04-18

  SM-164, a potent bivalent Smac mimetic, empowers researchers to dissect and induce TNFα-dependent apoptosis with high specificity in resistant cancer models. This article delivers actionable workflows, advanced troubleshooting, and evidence-backed protocol parameters, setting a new standard for apoptosis induction in tumor cell studies.

• ATRX-Deficient Glioma Sensitivity to RTK Inhibitors: Study I

  2026-04-17

  This study identifies that high-grade glioma cells with ATRX deficiency exhibit significantly increased sensitivity to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. The findings highlight the potential for stratified therapeutic strategies based on ATRX status, urging its consideration in future clinical trial designs.

• XAV-939: Precision Wnt/β-Catenin Modulation in Fibrosis & Bo

  2026-04-16

  XAV-939 (NVP-XAV939) stands out as a potent, selective tankyrase inhibitor, empowering researchers to dissect Wnt/β-catenin signaling in cancer, fibrosis, and bone biology. This guide translates recent scalable regenerative workflows and troubleshooting insights into protocol-ready strategies for superior experimental outcomes.

• Dovitinib (TKI-258): Precision RTK Inhibition in Cancer Mode

  2026-04-15

  Dovitinib (TKI-258, CHIR-258) is a multitargeted RTK inhibitor that enables robust, apoptosis-focused cancer research through precise ERK/STAT pathway suppression. This guide reveals advanced workflows, troubleshooting strategies, and actionable insights for maximizing Dovitinib’s translational impact in oncology studies.

• Sunitinib: Precision Multi-Targeted RTK Inhibitor Workflows

  2026-04-14

  Sunitinib from APExBIO delivers reproducible, high-sensitivity inhibition of multiple receptor tyrosine kinases, enabling advanced cancer research into angiogenesis, cell cycle arrest, and apoptosis. This article translates cutting-edge evidence—such as ATRX-deficiency sensitization in glioma—into optimized protocols, troubleshooting guides, and comparative insights for reliable experimental outcomes.

• Myriocin Restores Metabolic Balance in dAGE-Induced Obesity

  2026-04-13

  This study demonstrates that Myriocin, a selective serine palmitoyltransferase inhibitor, can reverse metabolic dysfunction in mice exposed to high dietary advanced glycation end products (dAGEs). By activating AMPK-PGC1α signaling and enhancing mitochondrial function, Myriocin offers a novel, evidence-based strategy for combating obesity and metabolic syndrome.

• Evaluating In Vitro Drug Responses: Insights from Fractional

  2026-04-13

  Schwartz's dissertation advances in vitro oncology research by dissecting the distinct contributions of proliferative arrest and cell death in anti-cancer drug evaluation. This work refines our understanding of drug action metrics, supporting more reproducible and interpretable preclinical assay design.

• EDI3 Inhibition Reduces Growth in HER2-Resistant Breast Canc

  2026-04-12

  Keller et al. (2023) identify EDI3 as a critical metabolic enzyme highly expressed in ER-HER2+ breast cancer cells that are resistant to HER2-targeted therapy. Inhibiting EDI3 reduces cell viability and tumor growth, highlighting a promising metabolic target in treatment-refractory breast cancer.

• BQCA Beyond Potentiation: GRK-Biased M1 Modulation for Advan

  2026-04-12

  Explore how Benzyl Quinolone Carboxylic Acid (BQCA) enables precision control of M1 muscarinic acetylcholine receptor signaling, with a focus on GRK-biased pathways. This article reveals new scientific insights and practical assay guidance for cognitive function and Alzheimer's disease research.

• Optimizing Protein Extraction with Protease and Phosphatase

  2026-04-11

  Unlock robust post-translational modification analysis and protein integrity preservation with the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This guide details advanced workflows, troubleshooting strategies, and science-backed enhancements for assays sensitive to proteolysis and dephosphorylation, including insights from lactate-driven HMGB1 research.

• TAK-242 (Resatorvid): Precision TLR4 Inhibition in Inflammat

  2026-04-11

  TAK-242 (Resatorvid) empowers researchers with selective, nanomolar-range suppression of TLR4-driven inflammation, enabling both robust in vitro cytokine modulation and translational neuroinflammation studies. Leveraging APExBIO's validated compound, advanced workflows can dissect immune pathways with unprecedented specificity and reproducibility.

• Optimizing Cancer Research Assays: Real-World Guidance wi...

  2026-04-10

  This scenario-driven guide addresses the practical challenges faced by cancer biology researchers using cell viability, proliferation, and cytotoxicity assays with advanced models. Leveraging Afatinib (SKU A4746) from APExBIO, we explore evidence-based strategies to enhance experimental reliability, data interpretation, and workflow efficiency, grounded in recent assembloid model breakthroughs.

• Afatinib (A4746): Irreversible ErbB Family Inhibitor for ...

  2026-04-09

  Afatinib is a potent, irreversible ErbB family tyrosine kinase inhibitor widely used in cancer biology research. It covalently blocks EGFR, HER2, and HER4, overcoming common resistance mutations such as T790M. This article provides a machine-readable, evidence-based overview of Afatinib’s mechanism, benchmarks, and optimal use in advanced cancer model systems.

• Dovitinib (TKI-258): Targeting RTK-Driven Tumor Microenvi...

  2026-04-08

  Explore how Dovitinib (TKI-258), a multitargeted receptor tyrosine kinase inhibitor, disrupts cancer cell survival by modulating hypoxia and immunometabolism in the tumor microenvironment. Discover unique insights on apoptosis induction and translational research applications.

15102 records 1/1007 page Next 12345 下5页 Last page